US Physical Therapy Inc (USPH): Target median analis

Tandha merek U.S. Physical Therapy (USPH)

The U.S. Physical Therapy (USPH) healthcare sector is susceptible to raw material logistics disruptions and international patenting complexities stemming from conflicts. This price chart clearly demonstrates the asset's dynamics, with a value of 96.69. The business generates revenue by expanding its network of physical therapy centers, where management is prioritizing partnerships, staff loyalty, and cost optimization to increase shareholder payouts.

US Physical Therapy (USPH) - Prakiraan konsensus analis saka 04.07.2022 nganti 22.10.2026

Rincian metrik lan analitis perusahaan U.S. Physical Therapy (USPH)

Analisis umum perusahaan:USPH - US Physical Therapy
Produk merek U.S. Physical Therapy, Inc.

Portfolio managers are closely monitoring the operational efficiency of U.S. Physical Therapy (USPH). This metric represents the weighted average of target prices from the expert community, reflecting the business's fundamental value. The price action of the analysts' target price indicator helps identify market imbalances relative to the real-time valuation. This is critical for the clinic network, as forecasts account for expansion rates and insurance reimbursements. Comparing the market price with this chart confirms the stability of the issuer's long-term positions.

Perusahaan pesaing

Prakiraan konsensus analis hcahealthcare.com (HCA)|Bagan rega target Tenet Healthcare Corporation THC|Target median analis Fresenius Medical Care AG (FMS)|SOLV - Bagan rega target|Bagan tingkat prakiraan EHC|UHS: Prakiraan konsensus analis|davita.com - Konsensus nilai wajar|Target konsensus RDNT|OPCH (Option Care) - Rega prakiraan analis|Bagan rega target Surgery Partners Corp (SGRY)|PINC (Premier Health) - Konsensus nilai wajar|Prakiraan konsensus analis EYE (National Vision Holdings)|progyny.com (PGNY) - Rata-rata rega prakiraan|Ardent Health Partners - Prakiraan konsensus analis|SEM - Prakiraan konsensus analis|ASTH (Apollo Medical Holdings) - Target konsensus|MD: Rega prakiraan analis|Bagan rega target The Pennant Group, Inc.|Target konsensus organogenesis.com (ORGO)|Prakiraan konsensus analis NUTX|AUNA - Rata-rata rega prakiraan|Bagan rega target sbc-holdings.com SBC|EOLS: Prakiraan gabungan firma investasi|CYH: Target konsensus|The Beauty Health - Rega prakiraan analis|MDWD (mediwound.com) - Target konsensus|Biote (BTMD) - Prakiraan konsensus analis|Target konsensus JYNT|DocGo, Inc (DCGO) - Target median analis|Bagan rega target P3 Health Partners Inc. (PIII)|Target median analis Gain Therapeutics Inc.|EUDA Health - Target konsensus|Target median analis Basel Medical (BMGL)|CLGN: Target konsensus|Konsensus nilai wajar CUPR (Cuprina Holdings Limited)|Concord Medical Services (CCM) - Bagan rega target|Bagan tingkat prakiraan AMS (ashs.com)|MRM (MEDIROM Healthcare Group) - Prakiraan konsensus analis|ALBT: Konsensus nilai wajar|Target konsensus DHAI (DIH Holding US Inc.)|XAGE - Rata-rata rega prakiraan|Bagan rega target NewGenIvf Group Limited NIVF|Target median analis ATI Physical Therapy Inc. (ATIP)|CareMax - Prakiraan konsensus analis|Target median analis Kindly MD Inc KDLY|MODV: Prakiraan konsensus analis|Target konsensus Novo Integrated Sciences Corp|SSY (SunLink Health Systems Inc.) - Prakiraan konsensus analis|Prakiraan konsensus analis imacholdings.comm